journal article·2018-08Open access

Silver Atomic Quantum Clusters of Three Atoms for Cancer Therapy: Targeting Chromatin Compaction to Increase the Therapeutic Index of Chemotherapy

Vanesa Porto, Erea Borrajo, David Buceta, Carmen Carneiro, Shahana Huseyinova, Blanca Domínguez, Kyra J. E. Borgman, Melike Lakadamyali, Maria F. Garcia‐Parajo, José Neissa, Tomás García‐Caballero, Giampaolo Barone, M. Carmen Blanco, Natalia Busto, Begoña García, José Maria Leal, José Blanco, José Rivas, M. Arturo López‐Quintela, Fernando Domínguez

Advanced Materials· Volume 30· Issue 33

Abstract

Abstract Nanomaterials with very low atomicity deserve consideration as potential pharmacological agents owing to their very small size and to their properties that can be precisely tuned with minor modifications to their size. Here, it is shown that silver clusters of three atoms (Ag3‐AQCs)—developed by an ad hoc method—augment chromatin accessibility. This effect only occurs during DNA replication. Coadministration of Ag3‐AQCs increases the cytotoxic effect of DNA‐acting drugs on human lung carcinoma cells. In mice with orthotopic lung tumors, the coadministration of Ag3‐AQCs increases the amount of cisplatin (CDDP) bound to the tumor DNA by fivefold without modifying CDDP levels in normal tissues. As a result, CDDP coadministered with Ag3‐AQCs more strongly reduces the tumor burden. Evidence of the significance of targeting chromatin compaction to increase the therapeutic index of chemotherapy is now provided.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanocluster Synthesis and Applications · Metal complexes synthesis and properties · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Physiology and Centro de Investigaciones en Medicina Molecular y Enfermedades Crónicas (CIMUS) IDIS Universidade de Santiago de Compostela 15782 Santiago de Compostela Spain

Departments of Physical Chemistry and Applied Physics Nanomag Laboratory IIT Universidade de Santiago de Compostela 15782 Santiago de Compostela Spain

ICFO‐Institut de Ciencies Fotoniques The Barcelona Institute of Science and Technology 08860 Castelldefels (Barcelona) Spain

Department of Physiology Perelman School of Medicine University of Pennsylvania Philadelphia PA 19104 USA

ICREA Pg. Lluís Companys 23 08010 Barcelona Spain

Department of Morphological Sciences School of Medicine‐University Clinical Hospital Universidade de Santiago de Compostela 15782 Santiago de Compostela Spain

Department of Biological Chemical and Pharmaceutical Sciences and Technologies University of Palermo 90128 Palermo Italy

Department of Chemistry University of Burgos 9001 Burgos Spain

International Iberian Nanotechnology Laboratory (INL) 4715 Braga Portugal

Funding

“la Caixa” Foundation · European Commission · H2020 European Research Council · European Regional Development Fund · Ministerio de Economía y Competitividad · Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia

References (38)

Show source-provided references
1. 10.1021/acs.chemrev.6b0076910.1021/acs.chemrev.6b00769 ↗
2. 10.1021/nn800632j10.1021/nn800632j ↗
3. 10.1007/978-3-540-32646-5_110.1007/978-3-540-32646-5_1 ↗
4. 10.1038/nmat238410.1038/nmat2384 ↗
5. 10.1002/anie.20080415410.1002/anie.200804154 ↗
6. 10.1021/ja804893b10.1021/ja804893b ↗
7. 10.1038/nchem.172110.1038/nchem.1721 ↗
8. 10.1126/science.122781310.1126/science.1227813 ↗
9. 10.1021/jp993691y10.1021/jp993691y ↗
10. 10.1021/acs.jpcc.5b1222710.1021/acs.jpcc.5b12227 ↗
11. 10.1021/ja410451m10.1021/ja410451m ↗
12. 10.1002/anie.20150291710.1002/anie.201502917 ↗
13. 10.1039/C5SC02022K10.1039/C5SC02022K ↗
14. 10.1016/j.jcis.2015.01.00110.1016/j.jcis.2015.01.001 ↗
15. 10.1016/j.chembiol.2010.04.01210.1016/j.chembiol.2010.04.012 ↗
16. 10.7554/eLife.0204210.7554/eLife.02042 ↗
17. 10.1016/S0092-8674(00)81958-310.1016/S0092-8674(00)81958-3 ↗
18. 10.1016/j.cub.2013.03.04310.1016/j.cub.2013.03.043 ↗
19. 10.1038/ncomms292110.1038/ncomms2921 ↗
20. 10.1038/nmeth92910.1038/nmeth929 ↗
21. 10.1016/j.jsb.2011.12.01510.1016/j.jsb.2011.12.015 ↗
22. 10.1016/j.cell.2015.01.05410.1016/j.cell.2015.01.054 ↗
23. 10.1016/j.febslet.2015.04.01210.1016/j.febslet.2015.04.012 ↗
24. 10.1038/nature1649610.1038/nature16496 ↗
25. 10.1146/annurev.bi.57.070188.00111110.1146/annurev.bi.57.070188.001111 ↗
26. 10.4049/jimmunol.167.8.449410.4049/jimmunol.167.8.4494 ↗
27. 10.1016/j.cell.2007.01.03010.1016/j.cell.2007.01.030 ↗
28. 10.1016/S0026-895X(24)09232-010.1016/S0026-895X(24)09232-0 ↗
29. 10.1038/cddis.2013.42810.1038/cddis.2013.428 ↗
30. 10.1038/onc.2011.38410.1038/onc.2011.384 ↗
31. 10.1146/annurev.pharmtox.48.080907.18042610.1146/annurev.pharmtox.48.080907.180426 ↗
32. Sharma A. · 2012
33. 10.1385/MB:26:3:24910.1385/MB:26:3:249 ↗
34. 10.1016/j.chembiol.2013.04.00710.1016/j.chembiol.2013.04.007 ↗
35. 10.2217/fon.09.12710.2217/fon.09.127 ↗
36. 10.1038/nrc216710.1038/nrc2167 ↗
37. 10.1038/s41467-017-01680-410.1038/s41467-017-01680-4 ↗
38. 10.1002/cmdc.20150047810.1002/cmdc.201500478 ↗